In this work we present our experiences with radioimmunoassay of plasma chromogranin A (CGA) in the laboratory diagnosis of neuroendocrine tumors classified as pheochromocytoma (PCC) and paraganglioma (PGL). Here, CGA is linked to pheochromocytoma.